NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.

New U of A-based study to examine very rare adverse events linked to COVID-19 vaccines

neutralizing antibodies – NIH Director's Blog

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

Cancer Researchers Combat COVID-19, COVID and Cancer Report

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

Vaccine Therapies for Cancer: Then and Now

Case Western Reserve University researchers study how the immune system responds to COVID-19 The Daily The Daily

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

Recent Advancement of Nanostructured Materials for Clinical Challenges in Vaccinology

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

How the National Cancer Act of 1971 Revolutionized Cancer Care and What Lies Ahead - The ASCO Post

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

Coronavirus infections - PAHO/WHO

COVID-19

Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

Coronavirus - OPAS/OMS Organização Pan-Americana da Saúde

Coronavirus disease 2019 (COVID-19) - Symptoms and causes - Mayo Clinic